Market Currents
Credit Suisse is recommends taking advantage of recent weakness to buy Health Management (HMA...
-
Monday, March 19, 2012, 12:55 PM ETCredit Suisse is recommends taking advantage of recent weakness to buy Health Management (HMA +0.7%). The firm says it's not concerned with recent headlines and believes organic growth estimates will prove conservative. The firm rates the shares at Outperform with a $12 price target.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
